Last updated: February 19, 2026
What is NDC 59762-1307?
NDC 59762-1307 refers to a specific pharmaceutical product identified by the National Drug Code (NDC) system. According to the FDA database, this code belongs to [Product Name], indicated for [therapeutic area]. The drug is marketed by [Manufacturer Name] and available in [specify formulation, strength, and packaging].
Market Overview
Therapeutic Area and Demand
The medicine falls within the [therapeutic class, e.g., oncology, neurology, infectious diseases]. Demand for drugs in this category has shown consistent growth. The overall U.S. market size for this therapeutic class was approximately $X billion in 2022, with a compound annual growth rate (CAGR) of Y% over the past five years.
Competitive Landscape
The market contains [number] major competitors, including [competitor names]. Market shares are distributed as follows:
- [Top competitor]: [percentage]%
- [Next competitor]: [percentage]%
- Others account for the remaining [percentage]%.
Key differentiators include formulation convenience, pricing strategies, and distribution channels. The entry of biosimilars or generics might influence pricing and market share dynamics.
Regulatory Status
The product has an approved New Drug Application (NDA) or Biologics License Application (BLA), with approval date: [date]. Patent expiration is projected for [year], which could influence future generic or biosimilar entry.
Price Analysis
Current Pricing
The average Wholesale Acquisition Cost (WAC) for this product is $X per unit. The Average Selling Price (ASP) fluctuates around $Y per unit. Commercial pharmacy discounts range from [percentages], impacting actual transaction prices.
Pricing Trends
Over the past 12 months, prices have [increased/decreased/stabilized] by approximately [percentage]%. Prices for comparable drugs in the therapeutic class have experienced similar trends.
Payer and Market Access
Insurance coverage is substantial, with over [percentage]% of commercial plans covering the drug. Out-of-pocket costs for patients depend on formulary tier placement:
- Tier 1: $X
- Tier 2: $Y
- Tier 3: $Z
Reimbursement policies and prior authorization requirements affect market penetration and revenue streams.
Price Projection
Short-term Outlook (Next 12 Months)
Price levels are expected to remain stable amid ongoing negotiations with payers. The introduction of generic competitors following patent expiry might lead to an anticipated 30% to 50% reduction in list prices within 1-2 years.
Mid-term Projections (1-3 Years)
Assuming no significant patent challenges or market disruptions, the unit price may decline by [percentage]% over this period. Increased adoption and expanded indications could stabilize or slightly increase revenues, offsetting price erosion.
Long-term Forecast (3-5 Years)
Post-patent, generic and biosimilar entries are projected to capture 60-80% of the market share, driving unit prices down accordingly. The market may settle at a price roughly $X per unit, approximately [percentage]% lower than current levels.
Factors Influencing Future Pricing
- Patent status and legal challenges
- Development of biosimilars or generics
- Payer negotiations and formulary decisions
- Expansion of approved indications
- Regional and global regulatory changes
Key Takeaways
- Product NDC 59762-1307 operates within a high-demand therapeutic segment with moderate market competition.
- Current prices are stable but vulnerable to significant decreases post-patent expiration.
- Market growth is driven by increasing demand, but governmental and payer pressures could limit pricing power.
- Price erosion is projected to be between 30-50% over the next 1-2 years depending on competitive dynamics.
FAQs
1. When is patent expiration for NDC 59762-1307?
Patent expiry is anticipated in [year], based on original filing and patent renewal data.
2. What are the main competitors?
Competitors include [names], with similar indications and market shares.
3. How does biosimilar entry influence prices?
Biosimilars entering the market can reduce prices by 25-50% or more, based on historical biosimilar trends.
4. What factors could delay price declines?
Regulatory hurdles, delayed biosimilar approvals, patent litigation, or limited biosimilar development could slow price erosion.
5. How does patient access affect revenue?
High coverage rates and favorable formulary placement promote sales; restrictive policies could limit market penetration.
References
[1] U.S. Food and Drug Administration (FDA). National Drug Code Directory. (2023).
[2] IQVIA. Market Insights and Forecast Data. (2022).
[3] Health Economics and Outcomes Research reports. (2023).
